Drug Type siRNA  | 
Synonyms BNC 1601, BNC-1601  | 
Target  | 
Action inhibitors  | 
Mechanism renin receptor inhibitors(ATPase H+ transporting accessory protein 2 inhibitors)  | 
Therapeutic Areas  | 
Active Indication  | 
Inactive Indication-  | 
Originator Organization  | 
Active Organization  | 
Inactive Organization-  | 
License Organization-  | 
Drug Highest PhasePreclinical  | 
First Approval Date-  | 
Regulation-  | 
| Indication | Highest Phase | Country/Location | Organization | Date | 
|---|---|---|---|---|
| Dystrophy, Macular | Preclinical | Japan   | 30 Jan 2022 | |
| Diabetic Retinopathy | Preclinical | Japan   | - | |
| Uveitis | Preclinical | Japan   | - | 





